P-ISSN 2587-2400 | E-ISSN 2587-196X
Contact
EJMO Home
|
Toggle navigation
EJMO HOME
ABOUT JOURNAL
EDITORIAL BOARD
INSTRUCTIONS FOR AUTHORS
FOR REVIEWERS
EJMO ARCHIVE
CONTACT
EJMO Volume :
8
Issue :
3
Year :
2024
COVID-19 in EJMO
8/3
EJMO Current Issue
EJMO Archive
EJMO & Congress
Most Cited Articles
Ahead of Print
Copyright Transfer Form
ICMJE COI Form
FHL2 Determines Poor Outcomes and Responsiveness of Immunotherapy Plus Tyrosine Kinase Inhibition in Metastatic Renal Cell Carcinoma
Copyright © 2024 Eurasian Journal of Medicine and Oncology, EJMO
EJMO & EJMO
